跳至主要内容
临床试验/TCTR20171106002
TCTR20171106002尚未招募4 期

Quantitative assessment of scalp cooling in chemotherapy induce alopecia : A randomized controlled trial

Ratchadapiseksompotch Fund (Pending)0 个研究点目标入组 40 人开始时间: 2017年11月6日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Female

入选标准

  • 1.Age 18-70 years old
  • 2.CA breast patient who recieve one of the following chemotherapy regimen : oxorubicin cyclophosphamide or taxane-based regimen as neoadjuvant chemotherapy or adjuvant chemotherapy
  • 3. At least 4 cycles of chemotherapy

排除标准

  • 1.History of previous chemotherapy treatment
  • 2.Alopecia at least gr.I before receiving chemotherapy
  • 3.History of migraine, hypothyroid, hepatitis, uncontrolled diabetes, cold intolerance, cryoglobulinemia, cryofibrinogenemia or cold agglutinin disease
  • 4.History of iron deficiency anemia
  • 5.History of oral contraceptive pill or hormone replacement therpary
  • 6.History of psychological disorder diagnosed by psychiatrist
  • 7.History of scalp disease
  • 8.History of previous alopecia treatmenr
  • 9.History of hair transplantation

研究者

发起方
Ratchadapiseksompotch Fund (Pending)

相似试验